Wed, February 19, 2020
Tue, February 18, 2020
Fri, February 14, 2020
Thu, February 13, 2020
Wed, February 12, 2020
Tue, February 11, 2020
Mon, February 10, 2020
Sun, February 9, 2020
Fri, February 7, 2020

Jason Gerberry Maintained (TEVA) at Sell with Increased Target to $11 on, Feb 13th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-11-on-feb-13th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Jason Gerberry of B of A Securities, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Sell with Increased Target from $8 to $11 on, Feb 13th, 2020.

Jason has made no other calls on TEVA in the last 4 months.



There are 5 other peers that have a rating on TEVA. Out of the 5 peers that are also analyzing TEVA, all agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Louise Chen of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $15 on, Wednesday, February 12th, 2020
  • Sel Hardy of "CFRA" Maintained at Hold with Increased Target to $13 on, Wednesday, February 12th, 2020
  • Jacob Hughes of "Wells Fargo" Maintained at Hold with Increased Target to $10 on, Wednesday, January 22nd, 2020
  • Chris Schott of "JP Morgan" Upgraded from Sell to Hold on, Tuesday, November 12th, 2019
  • David Amsellem of "Piper Sandler" Maintained at Hold with Increased Target to $7 on, Friday, November 8th, 2019

Publication Contributing Sources